Therapeutic considerations in spondyloarthritis patients who fail tumour necrosis factor antagonists

Best Practice and Research: Clinical Rheumatology

Volumn 24, Issue 5, 2010, Pages 683-692

  Ritchlin, C T ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

ankylosing spondylitis; failure; psoriatic arthritis; spondyloarthritis; TNF antagonist; treatment

Indexed keywords

ABATACEPT; AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; METHYLPREDNISOLONE SODIUM SUCCINATE; NONSTEROID ANTIINFLAMMATORY AGENT; PAMIDRONIC ACID; RETINOID; RITUXIMAB; SALAZOSULFAPYRIDINE; STEROID; THALIDOMIDE; TUMOR NECROSIS FACTOR INHIBITOR; USTEKINUMAB;

ANKYLOSING SPONDYLITIS; CLINICAL TRIAL; DISEASE ACTIVITY; HUMAN; INFECTION; LUNG INFECTION; PATIENT CARE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROBABILITY; PSORIATIC ARTHRITIS; REVIEW; TREATMENT FAILURE; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; URINARY TRACT INFECTION;

ARTHRITIS, PSORIATIC; HUMANS; SPONDYLARTHRITIS; SPONDYLITIS, ANKYLOSING; TREATMENT FAILURE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 78049439081     PISSN: 15216942     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.berh.2010.06.002     Document Type: Review

References (60)

1. J.M. Moll, I. Haslock, I.F. Macrae, and V. Wright Associations between ankylosing spondylitis, psoriatic arthritis, Reiter's disease, the intestinal arthropathies, and Behcet's syndrome Medicine (Baltimore) 53 1974 343 364
2. J. Braun, and J. Sieper Ankylosing spondylitis Lancet 369 2007 1379 1390
3. C. Ritchlin Psoriatic disease-from skin to bone Nature Clinical Practice. Rheumatology 3 2007 698 706
4. M.S. Heiberg, W. Koldingsnes, and K. Mikkelsen The comparative one-year performance of anti-tumor necrosis factor alpha drugs in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: results from a longitudinal, observational, multicenter study Arthritis and Rheumatism 59 2008 234 240
5. A.F. Kavanaugh, and C.T. Ritchlin Systematic review of treatments for psoriatic arthritis: an evidence based approach and basis for treatment guidelines The Journal of Rheumatology 33 2006 1417 1421
6. J. Sieper, A. Koenig, and S. Baumgartner Analysis of uveitis rates across all etanercept ankylosing spondylitis clinical trials Annals of the Rheumatic Diseases 69 2010 226 229
7. I.H. Song, H. Appel, and H. Haibel New onset of Crohn's disease during treatment of active ankylosing spondylitis with etanercept The Journal of Rheumatology 35 2008 532 536
8. A.B. Kimball, J.M. Jackson, and J.M. Sobell Reductions in healthcare resource utilization in psoriatic arthritis patients receiving etanercept therapy: results from the educate trial Journal of Drugs in Dermatology 6 2007 299 306
9. H. Dagfinrud, T.K. Kvien, and K.B. Hagen Physiotherapy interventions for ankylosing spondylitis Cochrane Database of Systematic Reviews 2008 CD002822
10. D. Durmus, G. Alayli, E. Cil, and F. Canturk Effects of a home-based exercise program on quality of life, fatigue, and depression in patients with ankylosing spondylitis Rheumatology International 29 2009 673 677
11. W. Hartung, C.J. Ross, and R. Straub Ultrasound-guided sacroiliac joint injection in patients with sacroiliitis: precise I.A. injection does not predict outcome Arthritis and Rheumatism 2009 69 [abstract]
12. J.H. Barlow, S.J. Macey, and G.R. Struthers Gender, depression, and ankylosing spondylitis Arthritis Care and Research 6 1993 45 51
13. R. Gunaydin, A. Goksel Karatepe, N. Cesmeli, and T. Kaya Fatigue in patients with ankylosing spondylitis: relationships with disease-specific variables, depression, and sleep disturbance Clinical Rheumatology 28 2009 1045 1051
14. I.H. Song, D.A. Poddubnyy, M. Rudwaleit, and J. Sieper Benefits and risks of ankylosing spondylitis treatment with nonsteroidal antiinflammatory drugs Arthritis and Rheumatism 58 2008 929 938
15. M. Rosenthal Is there a place for corticosteroids or immune modulation in treating Reiter's syndrome and ankylosing spondylitis? Annals of the Rheumatic Diseases 38 Suppl. 1 1979 suppl 100 suppl 101
16. M. Dougados, B. Dijkmans, and M. Khan Conventional treatments for ankylosing spondylitis Annals of the Rheumatic Diseases 61 Suppl. 3 2002 iii40 iii50
17. M.B. Richter, P. Woo, and G.S. Panayi The effects of intravenous pulse methylprednisolone on immunological and inflammatory processes in ankylosing spondylitis Clinical and Experimental Immunology 53 1983 51 59
18. N.D. Peters, and L. Ejstrup Intravenous methylprednisolone pulse therapy in ankylosing spondylitis Scandinavian Journal of Rheumatology 21 1992 134 138
19. R.T. Brodell, and L. Williams A corticosteroid-induced flare of psoriasis. How to control or, better yet, avoid Postgraduate Medicine 106 1999 31 32
20. C. De Bari, G. Lapadula, and F.P. Cantatore Coexisting psoriatic arthritis, gout, and chondrocalcinosis Scandinavian Journal of Rheumatology 27 1998 306 309
21. W. Martel, K.J. Stuck, A.M. Dworin, and R.G. Hylland Erosive osteoarthritis and psoriatic arthritis: a radiologic comparison in the hand, wrist, and foot AJR. American Journal of Roentgenology 134 1980 125 135
22. A.L. Tan, A.J. Grainger, and S.F. Tanner A high-resolution magnetic resonance imaging study of distal interphalangeal joint arthropathy in psoriatic arthritis and osteoarthritis: are they the same? Arthritis and Rheumatism 54 2006 1328 1333
23. H. Bardach ANF-negative subacute cutaneous lupus erythematosus with anti-Ro antibodies. A new subset of lupus with characteristic skin manifestations Hautarzt 33 1982 537 541
24. A.P. Anandarajah, and C.T. Ritchlin The diagnosis and treatment of early psoriatic arthritis Nature Reviews. Rheumatology 5 2009 634 641
25. A. Gulfe, L.E. Kristensen, and T. Saxne Rapid and sustained health utility gain in anti-tumour necrosis factor-treated inflammatory arthritis: observational data during 7 years in southern Sweden Annals of the Rheumatic Diseases 69 2010 352 357
26. M.S. Heiberg, C. Kaufmann, and E. Rodevand The comparative effectiveness of anti-TNF therapy and methotrexate in patients with psoriatic arthritis: 6-month results from a longitudinal, observational, multicentre study Annals of the Rheumatic Diseases 66 2007 1038 1042
27. E. Lie, D. van der Heijde, and T. Uhlig Effectiveness and retention rates of methotrexate in psoriatic arthritis in comparison with methotrexate-treated patients with rheumatoid arthritis Annals of the Rheumatic Diseases 69 2010 671 676
28. H. Raffayova, N. Kungurov, and A. Kubanova Infliximab plus methotrexate significantly improves synovitis and psoriatic lesions in methotrexate naive psoriatic arthritis (PsA) patients: results of the RESPOND trial Arthritis and Rheumatism 60 2009 1780 [abstract]
29. J.P. Kaltwasser, P. Nash, and D. Gladman Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis: a multinational, double-blind, randomized, placebo-controlled clinical trial Arthritis and Rheumatism 50 2004 1939 1950
30. D. Malesci, R. Tirri, R. Buono, and G. La Montagna Leflunomide in psoriatic arthritis: a retrospective study of discontinuation rate in daily clinical practice compared with methotrexate Clinical and Experimental Rheumatology 25 2007 881 884
31. E.R. Soriano, and N.J. McHugh Therapies for peripheral joint disease in psoriatic arthritis. A systematic review The Journal of Rheumatology 33 2006 1422 1430
32. L. Eder, V. Chandran, and J. Ueng Predictors of response to intra-articular steroid injection in psoriatic arthritis 2010 Rheumatology Oxford
33. J. Kabat-Zinn, E. Wheeler, and T. Light Influence of a mindfulness meditation-based stress reduction intervention on rates of skin clearing in patients with moderate to severe psoriasis undergoing phototherapy (UVB) and photochemotherapy (PUVA) Psychosomatic Medicine 60 1998 625 632
34. K.A. Papp, R.G. Langley, and M. Lebwohl Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2) Lancet 371 2008 1675 1684
35. C.E. Griffiths, B.E. Strober, and P. van de Kerkhof Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis The New England Journal of Medicine 362 2010 118 128
36. P.J. Mease, M. Genovese, and C. Ritchlin Abatacept in psoriatic arthritis: results of a phase II study Arthritis and Rheumatism 60 2009 1260 [abstract]
37. P. Mease, M. Genovese, and C. Ritchlin Rituximab in psoriatic arthritis: results of an open-label study Annals of the Rheumatic Diseases 2010 69 [abstract]
38. A.D. Fraser, A.W. van Kuijk, and R. Westhovens A randomised, double blind, placebo controlled, multicentre trial of combination therapy with methotrexate plus ciclosporin in patients with active psoriatic arthritis Annals of the Rheumatic Diseases 64 2005 859 864
39. S. D'Angelo, M.S. Cutro, and E. Lubrano Combination therapy with ciclosporin and etanercept in patients with psoriatic arthritis Annals of the Rheumatic Diseases 69 2010 934 935
40. J.C. Lee, D.D. Gladman, C.T. Schentag, and R.J. Cook The long-term use of azathioprine in patients with psoriatic arthritis Journal of Clinical Rheumatology 7 2001 160 165
41. M. Rudwaleit, A. Metter, and J. Listing Inflammatory back pain in ankylosing spondylitis: a reassessment of the clinical history for application as classification and diagnostic criteria Arthritis and Rheumatism 54 2006 569 578
42. R.D. Inman, and W.P. Maksymowych A double-blind, placebo-controlled trial of low dose infliximab in ankylosing spondylitis The Journal of Rheumatology 2010
43. C. Ritchlin, and F. Tausk A medical conundrum: onset of psoriasis in patients receiving anti-tumour necrosis factor agents Annals of the Rheumatic Diseases 65 2006 1541 1544
44. A.N. Collamer, K.T. Guerrero, J.S. Henning, and D.F. Battafarano Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: a literature review and potential mechanisms of action Arthritis and Rheumatism 59 2008 996 1001
45. J. Chen, C. Liu, and J. Lin Methotrexate for ankylosing spondylitis Cochrane Database of Systematic Reviews 2006 CD004524
46. H. Haibel, H.C. Brandt, and I.H. Song No efficacy of subcutaneous methotrexate in active ankylosing spondylitis: a 16-week open-label trial Annals of the Rheumatic Diseases 66 2007 419 421
47. A.N. Malaviya, S. Kapoor, and S. Garg A new strategy of drug treatment in NSAID-unresponsive ankylosing spondylitis: combination of pamidronate and methylprednisolone monthly intravenous infusions on the background of a combination of disease modifying drugs sulfasalazine and methotrexate The Journal of the Association of Physicians of India 55 2007 193 197
48. M. Can, S.Z. Aydýn, and A. Nideliolu Conventional DMARD therapy(methotrexate-sulphasalazine) may decrease switch to biologics in routine practice of ankylosing spondylitis patients Annals of the Rheumatic Diseases 2010 59 [abstract]
49. D.J. Pradeep, A.C. Keat, and K. Gaffney Switching anti-TNF therapy in ankylosing spondylitis Rheumatology (Oxford) 47 2008 1726 1727
50. F. Cantini, L. Niccoli, and M. Benucci Switching from infliximab to once-weekly administration of 50 mg etanercept in resistant or intolerant patients with ankylosing spondylitis: results of a fifty-four-week study Arthritis and Rheumatism 55 2006 812 816
51. L.C. Coates, L.S. Cawkwell, and N.W. Ng Real life experience confirms sustained response to long-term biologics and switching in ankylosing spondylitis Rheumatology (Oxford) 47 2008 897 900
52. E. Lie, D. van der Heijde, and T. Uhlig TNF inhibitors in ankylosing spondylitis (AS) in the NOR-DMARD register: is switching useful? Arthritis and Rheumatism 60 2009 527 [abstract]
53. I.H. Song, F. Heldmann, and M. Rudwaleit Different response to rituximab in tumor necrosis factor blocker-naive patients with active ankylosing spondylitis and in patients in whom tumor necrosis factor blockers have failed: a twenty-four-week clinical trial Arthritis and Rheumatism 62 2010 1290 1297
54. M. Breban, B. Gombert, B. Amor, and M. Dougados Efficacy of thalidomide in the treatment of refractory ankylosing spondylitis Arthritis and Rheumatism 42 1999 580 581
55. J.C. Wei, T.W. Chan, and H.S. Lin Thalidomide for severe refractory ankylosing spondylitis: a 6-month open-label trial The Journal of Rheumatology 30 2003 2627 2631
56. W.P. Maksymowych, G.S. Jhangri, and A.A. Fitzgerald A six-month randomized, controlled, double-blind, dose-response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug-refractory ankylosing spondylitis Arthritis and Rheumatism 46 2002 766 773
57. X. Wang, Z. Lin, and Q. Wei Expression of IL-23 and IL-17 and effect of IL-23 on IL-17 production in ankylosing spondylitis Rheumatology International 29 2009 1343 1347
58. H. Appel, G. Ruiz-Heiland, and J. Listing Altered skeletal expression of sclerostin and its link to radiographic progression in ankylosing spondylitis Arthritis and Rheumatism 60 2009 3257 3262
59. S. Cohen, and R. Fleischmann Kinase inhibitors: a new approach to rheumatoid arthritis treatment Current Opinion in Rheumatology 22 2010 330 335
60. A. Gottlieb, A. Menter, and A. Mendelsohn Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial Lancet 373 2009 633 640